Work

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

Year: 2001

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: C J Logothetis, K K Wu, L D Finn, D Daliani, W Figg, H Ghaddar, J U Gutterman

Institutions: The University of Texas MD Anderson Cancer Center, National Institutes of Health

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2148853628

FWCI: 4.232

Cites: 11

Cited by: 140

Related to: 10